[Postmenopausal malignant transformation of extragenital endometriosis. A case report]

B. Chung Fat, Fat BC, Terzibachian JJ, J.-J. Terzibachian, Govyadovskiy A, A. Govyadovskiy, Grisey A, A. Grisey
Gynecologie, obstetrique & fertilite · 2008 · vol. 36(1) , pp. 51–55 · doi:10.1016/j.gyobfe.2007.06.019 · PMID:18178119 · W1979575446
Case report OA: closed CC0 ⤵ 9 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

This case report details a postmenopausal patient who developed malignant transformation of extragenital endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Malignant transformation of endometriosis is a rare event. The ovaries are the most common sites reported in the literature. Postmenopausal cancer arising in extragenital endometriosis is still more exceptional. Hormone replacement therapy and perhaps, to a lesser extent, Tamoxifen could be risk factors for the malignant transformation of endometriosis. We herein report the case of a patient who has developed, after 11 years of hormone replacement therapy, an extragenital endometrioid carcinoma in the vesico-uterine pouch.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Carcinoma, Endometrioid Endometriosis Postmenopause Postmenopause Tamoxifen Uterine Neoplasms Aged Aged Antineoplastic Agents Antineoplastic Agents Antineoplastic Agents Carcinoma, Endometrioid Carcinoma, Endometrioid Carcinoma, Endometrioid Carcinoma, Endometrioid Cell Transformation, Neoplastic Cell Transformation, Neoplastic Endometriosis Endometriosis Endometriosis

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (36)

Cited by (10)

Source provenance

europepmc
last seen: 2026-10-13T06:10:10.580696+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:05:01.267406+00:00
unpaywall
last seen: 2026-10-13T06:25:51.201866+00:00
License: CC0 · commercial use OK